Skip to main content
Top
Published in: Journal of Translational Medicine 1/2009

Open Access 01-12-2009 | Research

Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis

Authors: Leo Jeng, Alexandra V Yamshchikov, Suzanne E Judd, Henry M Blumberg, Gregory S Martin, Thomas R Ziegler, Vin Tangpricha

Published in: Journal of Translational Medicine | Issue 1/2009

Login to get access

Abstract

Background

Vitamin D insufficiency is common in hospitalized patients. Recent evidence suggests that vitamin D may enhance the innate immune response by induction of cathelicidin (LL-37), an endogenous antimicrobial peptide produced by macrophages and neutrophils. Thus, the relationship between vitamin D status and LL-37 production may be of importance for host immunity, but little data is available on this subject, especially in the setting of human sepsis syndrome and other critical illness.

Methods

Plasma concentrations of 25-hydroxyvitamin D (25(OH)D), vitamin D binding protein (DBP) and LL-37 in critically ill adult subjects admitted to intensive care units (ICUs) with sepsis and without sepsis were compared to healthy controls.

Results

Critically ill subjects had significantly lower plasma 25(OH)D concentrations compared to healthy controls. Mean plasma LL-37 levels were significantly lower in critically ill subjects compared to healthy controls. Vitamin D binding protein levels in plasma were significantly lower in critically ill subjects with sepsis compared to critically ill subjects without sepsis. There was a significant positive association between circulating 25(OH)D and LL-37 levels.

Conclusion

This study demonstrates an association between critical illness and lower 25(OH)D and DBP levels in critically ill patients as compared to healthy controls. It also establishes a positive association between vitamin D status and plasma LL-37, which suggests that systemic LL-37 levels may be regulated by vitamin D status. Optimal vitamin D status may be important for innate immunity especially in the setting of sepsis. Further invention studies to examine this association are warranted.
Appendix
Available only for authorised users
Literature
2.
go back to reference Adams JS, Hewison M: Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab. 2008, 4 (2): 80-90.PubMedCentralCrossRefPubMed Adams JS, Hewison M: Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab. 2008, 4 (2): 80-90.PubMedCentralCrossRefPubMed
3.
go back to reference Liu PT, Stenger S, Li H: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006, 311 (5768): 1770-3.CrossRefPubMed Liu PT, Stenger S, Li H: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006, 311 (5768): 1770-3.CrossRefPubMed
4.
go back to reference Dürr UH, Sudheendra US, Ramamoorthy A: LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta. 2006, 1758 (9): 1408-25.CrossRefPubMed Dürr UH, Sudheendra US, Ramamoorthy A: LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta. 2006, 1758 (9): 1408-25.CrossRefPubMed
5.
go back to reference Nierman DM, Mechanick JI: Bone hyperresorption is prevalent in chronically critically ill patients. Chest. 1998, 114 (4): 1122-8.CrossRefPubMed Nierman DM, Mechanick JI: Bone hyperresorption is prevalent in chronically critically ill patients. Chest. 1998, 114 (4): 1122-8.CrossRefPubMed
6.
go back to reference Berghe Van den G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R: Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab. 2003, 88 (10): 4623-32.CrossRefPubMed Berghe Van den G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R: Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab. 2003, 88 (10): 4623-32.CrossRefPubMed
7.
go back to reference Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical Care Medicine. 2001, 29 (7): 1303-10.CrossRefPubMed Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical Care Medicine. 2001, 29 (7): 1303-10.CrossRefPubMed
8.
go back to reference Grant WB: Solar ultraviolet-B irradiance and vitamin D may reduce the risk of septicemia. Dermato-Endocrinology. 2009, 1 (1): 1-6.CrossRef Grant WB: Solar ultraviolet-B irradiance and vitamin D may reduce the risk of septicemia. Dermato-Endocrinology. 2009, 1 (1): 1-6.CrossRef
9.
go back to reference Asakura H, Aoshima K, Suga Y: Beneficial effect of the active form of vitamin D3 against LPS-induced DIC but not against tissue-factor-induced DIC in rat models. Thrombosis & Haemostasis. 2001, 85 (2): 287-90. Asakura H, Aoshima K, Suga Y: Beneficial effect of the active form of vitamin D3 against LPS-induced DIC but not against tissue-factor-induced DIC in rat models. Thrombosis & Haemostasis. 2001, 85 (2): 287-90.
10.
go back to reference Moller S, Laigaard F, Olgaard K, Hemmingsen C: Effect of 1,25-dihydroxy-vitamin D3 in experimental sepsis. International Journal of Medical Sciences. 2007, 4 (4): 190-5.PubMedCentralCrossRefPubMed Moller S, Laigaard F, Olgaard K, Hemmingsen C: Effect of 1,25-dihydroxy-vitamin D3 in experimental sepsis. International Journal of Medical Sciences. 2007, 4 (4): 190-5.PubMedCentralCrossRefPubMed
11.
go back to reference Equils O, Naiki Y, Shapiro AM: 1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells. Clin Exp Immunol. 2006, 143 (1): 58-64.PubMedCentralCrossRefPubMed Equils O, Naiki Y, Shapiro AM: 1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells. Clin Exp Immunol. 2006, 143 (1): 58-64.PubMedCentralCrossRefPubMed
12.
go back to reference Sadeghi K, Wessner B, Laggner U: Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. European Journal of Immunology. 2006, 36 (2): 361-70.CrossRefPubMed Sadeghi K, Wessner B, Laggner U: Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. European Journal of Immunology. 2006, 36 (2): 361-70.CrossRefPubMed
13.
go back to reference Bukoski RD, Xue H: On the vascular inotropic action of 1,25-(OH)2 vitamin D3. American Journal of Hypertension. 1993, 6 (5 Pt 1): 388-96.PubMed Bukoski RD, Xue H: On the vascular inotropic action of 1,25-(OH)2 vitamin D3. American Journal of Hypertension. 1993, 6 (5 Pt 1): 388-96.PubMed
14.
go back to reference Dahl B, Schiødt FV, Ott P, Wians F, Lee WM, Balko J, O'Keefe GE: Plasma concentration of Gc-globulin is associated with organ dysfunction and sepsis after injury. Crit Care Med. 2003, 31 (1): 152-6.CrossRefPubMed Dahl B, Schiødt FV, Ott P, Wians F, Lee WM, Balko J, O'Keefe GE: Plasma concentration of Gc-globulin is associated with organ dysfunction and sepsis after injury. Crit Care Med. 2003, 31 (1): 152-6.CrossRefPubMed
15.
go back to reference Levy MM, Fink MP, Marshall JC: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine. 2003, 31 (4): 1250-6.CrossRefPubMed Levy MM, Fink MP, Marshall JC: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine. 2003, 31 (4): 1250-6.CrossRefPubMed
16.
go back to reference Berghe van den G, Weekers F, Baxter RC, Wouters P, Iranmanesh A, Bouillon R, Veldhuis JD: Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. J Clin Endocrinol Metab. 2001, 86 (7): 3217-26.PubMed Berghe van den G, Weekers F, Baxter RC, Wouters P, Iranmanesh A, Bouillon R, Veldhuis JD: Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. J Clin Endocrinol Metab. 2001, 86 (7): 3217-26.PubMed
17.
go back to reference Berghe Van den G, Baxter RC, Weekers F, Wouters P, Bowers CY, Iranmanesh A, Veldhuis JD, Bouillon R: The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol (Oxf). 2002, 56 (5): 655-69.CrossRef Berghe Van den G, Baxter RC, Weekers F, Wouters P, Bowers CY, Iranmanesh A, Veldhuis JD, Bouillon R: The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol (Oxf). 2002, 56 (5): 655-69.CrossRef
18.
go back to reference Berghe Van den G, Wouters P, Weekers F, Mohan S, Baxter RC, Veldhuis JD, Bowers CY, Bouillon R: Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab. 1999, 84 (4): 1311-23.PubMed Berghe Van den G, Wouters P, Weekers F, Mohan S, Baxter RC, Veldhuis JD, Bowers CY, Bouillon R: Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab. 1999, 84 (4): 1311-23.PubMed
19.
go back to reference Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS: Hypovitaminosis D in medical inpatients. N Engl J Med. 1998, 338 (12): 777-83.CrossRefPubMed Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS: Hypovitaminosis D in medical inpatients. N Engl J Med. 1998, 338 (12): 777-83.CrossRefPubMed
20.
go back to reference Kiebzak GM, Moore NL, Margolis S, Hollis B, Kevorkian CG: Vitamin D status of patients admitted to a hospital rehabilitation unit: relationship to function and progress. Am J Phys Med Rehabil. 1998, 86 (6): 777-83. Kiebzak GM, Moore NL, Margolis S, Hollis B, Kevorkian CG: Vitamin D status of patients admitted to a hospital rehabilitation unit: relationship to function and progress. Am J Phys Med Rehabil. 1998, 86 (6): 777-83.
21.
go back to reference Giusti A, Barone A, Razzano M, Pizzonia M, Oliveri M, Palummeri E, Pioli G: High prevalence of secondary hyperparathyroidism due to hypovitaminosis D in hospitalized elderly with and without hip fracture. J Endocrinol Invest. 2006, 29 (9): 809-13.CrossRefPubMed Giusti A, Barone A, Razzano M, Pizzonia M, Oliveri M, Palummeri E, Pioli G: High prevalence of secondary hyperparathyroidism due to hypovitaminosis D in hospitalized elderly with and without hip fracture. J Endocrinol Invest. 2006, 29 (9): 809-13.CrossRefPubMed
22.
go back to reference ASPEN Board of Directors and the Clinical Guidelines Task Force: Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002, 26 (1 Suppl): 1SA-138SA. ASPEN Board of Directors and the Clinical Guidelines Task Force: Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002, 26 (1 Suppl): 1SA-138SA.
23.
go back to reference Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ: Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003, 77 (1): 204-10.PubMed Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ: Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003, 77 (1): 204-10.PubMed
24.
go back to reference Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, Melsen F, Christensen EI, Willnow TE: An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell. 1999, 96 (4): 507-15.CrossRefPubMed Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, Melsen F, Christensen EI, Willnow TE: An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell. 1999, 96 (4): 507-15.CrossRefPubMed
25.
go back to reference White P, Cooke N: The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab. 2000, 11 (8): 320-7.CrossRefPubMed White P, Cooke N: The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab. 2000, 11 (8): 320-7.CrossRefPubMed
26.
go back to reference Speeckaert M, Huang G, Delanghe JR, Taes YE: Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta. 2006, 372 (1–2): 33-42.CrossRefPubMed Speeckaert M, Huang G, Delanghe JR, Taes YE: Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta. 2006, 372 (1–2): 33-42.CrossRefPubMed
27.
go back to reference Ramanathan B, Davis EG, Ross CR, Blecha F: Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity. Microbes Infect. 2002, 4 (3): 361-372.CrossRefPubMed Ramanathan B, Davis EG, Ross CR, Blecha F: Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity. Microbes Infect. 2002, 4 (3): 361-372.CrossRefPubMed
28.
go back to reference Cirioni O, Giacometti A, Ghiselli R: LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. Antimicrob Agents Chemother. 2006, 50 (5): 1672-1679.PubMedCentralCrossRefPubMed Cirioni O, Giacometti A, Ghiselli R: LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. Antimicrob Agents Chemother. 2006, 50 (5): 1672-1679.PubMedCentralCrossRefPubMed
29.
go back to reference Kirikae T, Hirata M, Yamasu H: Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia. Infect Immun. 1998, 66 (5): 1861-1868.PubMedCentralPubMed Kirikae T, Hirata M, Yamasu H: Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia. Infect Immun. 1998, 66 (5): 1861-1868.PubMedCentralPubMed
30.
go back to reference Nursyam EW, Amin Z, Rumende CM: The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Medica Indonesiana. 2006, 38 (1): 3-PubMed Nursyam EW, Amin Z, Rumende CM: The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Medica Indonesiana. 2006, 38 (1): 3-PubMed
32.
go back to reference Stryjewski ME, Hall RP, Chu VH: Expression of antimicrobial peptides in the normal and involved skin of patients with infective cellulitis. Journal of Infectious Diseases. 2007, 196 (9): 1425-30.CrossRefPubMed Stryjewski ME, Hall RP, Chu VH: Expression of antimicrobial peptides in the normal and involved skin of patients with infective cellulitis. Journal of Infectious Diseases. 2007, 196 (9): 1425-30.CrossRefPubMed
33.
go back to reference Beisswenger C, Bals R: Antimicrobial peptides in lung inflammation. Chem Immunol Allergy. 2005, 86: 55-71.CrossRefPubMed Beisswenger C, Bals R: Antimicrobial peptides in lung inflammation. Chem Immunol Allergy. 2005, 86: 55-71.CrossRefPubMed
Metadata
Title
Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis
Authors
Leo Jeng
Alexandra V Yamshchikov
Suzanne E Judd
Henry M Blumberg
Gregory S Martin
Thomas R Ziegler
Vin Tangpricha
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2009
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-7-28

Other articles of this Issue 1/2009

Journal of Translational Medicine 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.